Double-blind study of adjuvant buspirone for fluoxetine-treated patients with obsessive-compulsive disorder
- 1 May 1993
- journal article
- clinical trial
- Published by American Psychiatric Association Publishing in American Journal of Psychiatry
- Vol. 150 (5) , 819-821
- https://doi.org/10.1176/ajp.150.5.819
Abstract
In a double-blind, crossover study, 13 fluoxetine-treated patients with obsessive-compulsive disorder were given adjuvant buspirone and placebo for 4 weeks each. There were no significant differences between buspirone and placebo in obsessive-compulsive, depressive, or anxiety symptoms.Keywords
This publication has 15 references indexed in Scilit:
- Seizure Associated with Fluoxetine and Adjuvant Buspirone TherapyJournal of Clinical Psychopharmacology, 1992
- A Controlled Trial of Lithium Augmentation in Fluvoxamine-Refractory Obsessive-Compulsive DisorderJournal of Clinical Psychopharmacology, 1991
- Controlled Comparisons of Clomipramine and Fluoxetine in the Treatment of Obsessive-Compulsive DisorderArchives of General Psychiatry, 1990
- The Yale-Brown Obsessive Compulsive ScaleArchives of General Psychiatry, 1989
- Efficacy of Fluvoxamine in Obsessive-Compulsive DisorderArchives of General Psychiatry, 1989
- Combined lithium-tricyclic treatment of obsessive-compulsive disorderBiological Psychiatry, 1988
- Drug treatment of obsessive-compulsive disorderJournal of Affective Disorders, 1987
- Fluoxetine Treatment of Obsessive-Compulsive DisorderJournal of Clinical Psychopharmacology, 1985
- L-tryptophan in obsessive-compulsive disordersAmerican Journal of Psychiatry, 1977
- A RATING SCALE FOR DEPRESSIONJournal of Neurology, Neurosurgery & Psychiatry, 1960